Recent Advances in Lipid Nano-Carrier Systems for the Management of Inflammatory Diseases: A Comprehensive Review

Abstract

Background: In the past two decades, extensive research has focused on lipid nanocarriers for targeted drug delivery to treat various diseases. Among these, inflammatory conditions pose a formidable challenge in modern healthcare, encompassing a diverse spectrum from autoimmune disorders to chronic inflammation. Effective therapeutic interventions necessitate the development of targeted and efficient delivery systems to address the complexities associated with drug administration.

Purpose: This review highlights different approaches of lipid-based nanocarriers to target various inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease (IBD), psoriasis, asthma, and chronic obstructive pulmonary disease (COPD). It focuses on the advancements made in Lipid Nano-Carriers (LNC) with a special emphasis on their inherent safety, lower stability costs, and enhanced encapsulation efficiency.

Methods: Recent literature has been surveyed from PUBMED, GOOGLE SCHOLAR, etc., like search engines, for summarising detailed ongoing developments in the field of lipid nanocarriers for inflammatory diseases, which could prove to be a novel carrier for efficient drug delivery with special emphasis on surface modifications, formulations, pharmacokinetics, and efficacy.

Conclusion: This review emphasizes recent researches in the field of lipid-based nano formulations for managing inflammatory disease, as well as extensive discussion on their limitations and future prospective.

  • Page Number : 77-92
  • Published Date : 2023-11-10
  • Keywords
    Chronic obstructive pulmonary disease, Encapsulation efficiency, Inflammatory bowel disease, Lipid nanocarriers, Psoriasis, Pharmacokinetics
  • DOI Number
    10.15415/jprtm.2023.112001
  • Authors
    Kumar Anand , Sayak Khawas , Apurva Singh , Rashmi Kumari and Neelima Sharma

References

  • Abdelkader, H., Alani, A. W., & Alany, R. G. (2014). Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug delivery, 21(2), 87–100. https://doi.org/10.3109/10717544.2013.838077
  • Agrawal, Y. O., Mahajan, U. B., Mahajan, H. S., & Ojha, S. (2020). Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies. International journal of nanomedicine, 15, 4763–4778. https://doi.org/10.2147/IJN.S247007
  • Agrawal, Y., Petkar, K. C., & Sawant, K. K. (2010). Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. International journal of pharmaceutics, 401(1-2), 93–102. https://doi.org/10.1016/j.ijpharm.2010.09.007
  • Aib, S., Iqbal, K., Khan, N., Khalid, S., Adnan, M., Umair, S. M., & Dar, M. J. (2022). pH-sensitive liposomes for colonic co-delivery of mesalazine and curcumin for the treatment of ulcerative colitis. Journal of Drug Delivery Science and Technology, 72, 103335. https://doi.org/10.1016/j.jddst.2022.103335
  • Akombaetwa, N., Ilangala, A. B., Thom, L., Memvanga, P. B., Witika, B. A., & Buya, A. B. (2023). Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications. Pharmaceutics, 15(2), 656. https://doi.org/10.3390/pharmaceutics15020656
  • Algahtani, M. S., Ahmad, M. Z., & Ahmad, J. (2020). Nanoemulsion loaded polymeric hydrogel for topical delivery of curcumin in psoriasis. Journal of Drug Delivery Science and Technology, 59, 101847. https://doi.org/10.1016/j.jddst.2020.101847
  • Alipour, G., Dashti, S., & Hosseinzadeh, H. (2014). Review of pharmacological effects of Myrtuscommunis L. and its active constituents. Phytotherapy research: PTR, 28(8), 1125–1136. https://doi.org/10.1002/ptr.5122
  • Armstrong, A. W., & Read, C. (2020). Pathophysiology, clinical presentation, and treatment of psoriasis: a review. Jama, 323(19), 1945-1960. https://doi.org/10.1001/jama.2020.4006
  • Bayón-Cordero, L., Alkorta, I., & Arana, L. (2019).Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs. Nanomaterials (Basel, Switzerland), 9(3), 474. https://doi.org/10.3390/nano9030474
  • Beloqui, A., Memvanga, P. B., Coco, R., Reimondez-Troitiño, S., Alhouayek, M., Muccioli, G. G., Alonso, M. J., Csaba, N., de la Fuente, M., & Préat, V. (2016). A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease. Colloids and surfaces. B, Biointerfaces, 143, 327–335. https://doi.org/10.1016/j.colsurfb.2016.03.038
  • Bhardwaj, P., Tripathi, P., Pandey, S., Gupta, R., & Patil, P. R. (2022). Cyclosporine and pentoxifylline laden tailored niosomes for the effective management of psoriasis: in-vitro optimization, ex-vivo and animal study. International Journal of Pharmaceutics, 626, 122143. https://doi.org/10.1016/j.ijpharm.2022.122143
  • Bruner, L. P., White, A. M., & Proksell, S. (2023). Inflammatory Bowel Disease. Primary care, 50(3), 411–427. https://doi.org/10.1016/j.pop.2023.03.009
  • Campanati, A., Marani, A., Martina, E., Diotallevi, F., Radi, G., & Offidani, A. (2021). Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines, 9(11), 1511. https://doi.org/10.3390/biomedicines9111511
  • Capon, F., Burden, A. D., Trembath, R. C., & Barker, J. N. (2012). Psoriasis and other complex trait dermatoses: from Loci to functional pathways. Journal of investigative dermatology, 132(3), 915-922. https://doi.org/10.1038/jid.2011.395
  • Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., ... & Zhao, L. (2018). Inflammatory responses and inflammation-associated diseases in organs. Oncotarget, 9(6), 7204. https://doi.org/10.18632/oncotarget.23208
  • Cho, S. K., Kim, D., Won, S., Lee, J., Choi, C. B., Choe, J. Y., Hong, S. J., Jun, J. B., Kim, T. H., Koh, E., Lee, H. S., Lee, J., Yoo, D. H., Yoon, B. Y., Bae, S. C., & Sung, Y. K. (2019). Factors associated with time to diagnosis from symptom onset in patients with early rheumatoid arthritis. The Korean journal of internal medicine, 34(4), 910–916. https://doi.org/10.3904/kjim.2017.113
  • Cukic, V., Lovre, V., Dragisic, D., & Ustamujic, A. (2012). Asthma and Chronic Obstructive Pulmonary Disease (COPD) - Differences and Similarities. Materia socio-medica, 24(2), 100–105. https://doi.org/10.5455/msm.2012.24.100-105
  • Das, S., Ghosh, S., De, A. K., & Bera, T. (2017). Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis. International journal of biological macromolecules, 102, 996–1008. https://doi.org/10.1016/j.ijbiomac.2017.04.098
  • Day, A. S., & Lemberg, D. A. (2020). Identification and diagnosis of Crohn disease and ulcerative colitis in children. Journal of paediatrics and child health, 56(11), 1731–1734. https://doi.org/10.1111/jpc.14925
  • Dianzani, C., Foglietta, F., Ferrara, B., Rosa, A. C., Muntoni, E., Gasco, P., ... & Serpe, L. (2017). Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model. World journal of gastroenterology, 23(23), 4200. https://doi.org/10.3748/wjg.v23.i23.4200
  • Doktorovova, S., Kovačević, A. B., Garcia, M. L., & Souto, E. B. (2016). Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation. European Journal of Pharmaceutics and Biopharmaceutics, 108, 235-252. https://doi.org/10.1016/j.ejpb.2016.08.001
  • Doppalapudi, S., Jain, A., Chopra, D. K., & Khan, W. (2017). Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis. European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences, 96, 515–529. https://doi.org/10.1016/j.ejps.2016.10.025
  • Ferrara, G., Petrillo, M. G., Giani, T., Marrani, E., Filippeschi, C., Oranges, T., Simonini, G., & Cimaz, R. (2019). Clinical Use and Molecular Action of Corticosteroids in the Pediatric Age. International journal of molecular sciences, 20(2), 444. https://doi.org/10.3390/ijms20020444
  • Garg, N. K., Tandel, N., Bhadada, S. K., & Tyagi, R. K. (2021). Nanostructured Lipid Carrier-Mediated Transdermal Delivery of Aceclofenac Hydrogel Present an Effective Therapeutic Approach for Inflammatory Diseases. Frontiers in pharmacology, 12, 713616. https://doi.org/10.3389/fphar.2021.713616
  • Garg, N. K., Tyagi, R. K., Singh, B., Sharma, G., Nirbhavane, P., Kushwah, V., ... & Katare, O. P. (2016). Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1. International journal of pharmaceutics, 499(1-2), 301-320. https://doi.org/10.1016/j.ijpharm.2015.12.061
  • Ge, X., Wei, M., He, S., & Yuan, W. E. (2019).Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery. Pharmaceutics, 11(2), 55. https://doi.org/10.3390/pharmaceutics11020055
  • Ghasemiyeh, P., & Mohammadi-Samani, S. (2018). Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Research in pharmaceutical sciences, 13(4), 288–303. https://doi.org/10.4103/1735-5362.235156
  • Gordillo-Galeano, A., & Mora-Huertas, C. E. (2018). Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. European Journal of Pharmaceutics and Biopharmaceutics, 133, 285-308. https://doi.org/10.1016/j.ejpb.2018.10.017
  • Guo, Q., Wang, Y., Xu, D., Nossent, J., Pavlos, N. J., & Xu, J. (2018). Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone research, 6, 15. https://doi.org/10.1038/s41413-018-0016-9
  • Honmane, S., Hajare, A., More, H., Osmani, R. A. M., & Salunkhe, S. (2019). Lung delivery of nanoliposomal salbutamol sulfate dry powder inhalation for facilitated asthma therapy. Journal of liposome research, 29(4), 332-342. https://doi.org/10.1080/08982104.2018.1531022
  • Huguet-Casquero, A., Xu, Y., Gainza, E., Pedraz, J. L., & Beloqui, A. (2020). Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis. International journal of pharmaceutics, 586, 119515. https://doi.org/10.1016/j.ijpharm.2020.119515
  • Hussein, J., El-Bana, M. A., El-kHayat, Z., El-Naggar, M. E., Farrag, A. R., & Medhat, D. (2022). Eicosapentaenoic acid loaded silica nanoemulsion attenuates hepatic inflammation through the enhancement of cell membrane components. Biological procedures online, 24(1), 11. https://doi.org/10.1186/s12575-022-00173-z
  • Janakiraman, K., Krishnaswami, V., Rajendran, V., Natesan, S., & Kandasamy, R. (2018). Novel nano therapeutic materials for the effective treatment of rheumatoid arthritis-recent insights. Materials today. Communications, 17, 200–213. https://doi.org/10.1016/j.mtcomm.2018.09.011
  • John, R., Monpara, J., Swaminathan, S., & Kalhapure, R. (2024). Chemistry and Art of Developing Lipid Nanoparticles for Biologics Delivery: Focus on Development and Scale-Up. Pharmaceutics, 16(1), 131. https://doi.org/10.3390/pharmaceutics16010131
  • Kahnert, K., Jörres, R. A., Behr, J., & Welte, T. (2023). The Diagnosis and Treatment of COPD and Its Comorbidities. DeutschesArzteblatt international, 120(25), 434–444. https://doi.org/10.3238/arztebl.m2023.027
  • Kaur, N., Sharma, K., & Bedi, N. (2018). Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis. Pharmaceutical nanotechnology, 6(2), 133–143. https://doi.org/10.2174/2211738506666180523112513
  • Kaur, S., Goyal, A., Rai, A., Sharma, A., Ugoeze, K.C. & Singh, I. (2023). Quercetin nanoformulations: recent advancements and therapeutic applications. Advances in Natural Sciences: Nanoscience and Nanotechnology, 14(3), p.033002. https://doi.org10.1088/2043-6262/acedaa
  • Kazi, K. M., Mandal, A. S., Biswas, N., Guha, A., Chatterjee, S., Behera, M., & Kuotsu, K. (2010).Niosome: A future of targeted drug delivery systems. Journal of advanced pharmaceutical technology & research, 1(4), 374–380. https://doi.org/10.4103/0110-5558.76435
  • Knight A. (2020). Managing the overlap of asthma and chronic obstructive pulmonary disease. Australian prescriber, 43(1), 7–11. https://doi.org/10.18773/austprescr.2020.002
  • Krishnan, Y., Mukundan, S., Akhil, S., Gupta, S., & Viswanad, V. (2018). Enhanced Lymphatic Uptake of Leflunomide Loaded Nanolipid Carrier via Chylomicron Formation for the Treatment of Rheumatoid Arthritis. Advanced pharmaceutical bulletin, 8(2), 257–265. https://doi.org/10.15171/apb.2018.030
  • Kumar Sarwa, K., Rudrapal, M., & Mazumder, B. (2015). Topical ethosomal capsaicin attenuates edema and nociception in arthritic rats. Drug delivery, 22(8), 1043–1052. https://doi.org/10.3109/10717544.2013.861041
  • Lei, F., Zeng, F., Yu, X., Deng, Y., Zhang, Z., Xu, M., ... & Li, C. (2023). Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair. Journal of Nanobiotechnology, 21(1), 275. https://doi.org/10.1186/s12951-023-02045-4
  • Leong, E. W. X., & Ge, R. (2022). Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics. Biomedicines, 10(9), 2179. https://doi.org/10.3390/biomedicines10092179
  • Li, N., Qin, Y., Dai, D., Wang, P., Shi, M., Gao, J., Yang, J., Xiao, W., Song, P., & Xu, R. (2022). Transdermal Delivery of Therapeutic Compounds With Nanotechnological Approaches in Psoriasis. Frontiers in bioengineering and biotechnology, 9, 804415. https://doi.org/10.3389/fbioe.2021.804415
  • Li, Y., Ji, Z., Wang, Y., Li, X., & Xie, Y. (2022). Breathing Exercises in the Treatment of COPD: An Overview of Systematic Reviews. International journal of chronic obstructive pulmonary disease, 17, 3075–3085. https://doi.org/10.2147/COPD.S385855
  • Liao, C. C., Yu, H. P., Yang, S. C., Alalaiwe, A., Dai, Y. S., Liu, F. C., & Fang, J. Y. (2021). Multifunctional lipid-based nanocarriers with antibacterial and anti-inflammatory activities for treating MRSA bacteremia in mice. Journal of nanobiotechnology, 19(1), 48.https://doi.org/10.1186/s12951-021-00789-5
  • Lin, Y. K., Huang, Z. R., Zhuo, R. Z., & Fang, J. Y. (2010). Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. International journal of nanomedicine, 5, 117–128. https://doi.org/10.2147/ijn.s9155
  • Liu, H., Li, Y., Zhang, X., Shi, M., Li, D., & Wang, Y. (2022). Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats. Canadian respiratory journal, 2022, 8509396. https://doi.org/10.1155/2022/8509396
  • Lv, C., Li, H., Cui, H., Bi, Q., & Wang, M. (2021). Solid lipid nanoparticle delivery of rhynchophylline enhanced the efficiency of allergic asthma treatment via the upregulation of suppressor of cytokine signaling 1 by repressing the p38 signaling pathway. Bioengineered, 12(1), 8635-8649. https://doi.org/10.1080/21655979.2021.1988364
  • Marinho, S., Illanes, M., Ávila-Román, J., Motilva, V., & Talero, E. (2021). Anti-inflammatory effects of rosmarinic acid-loaded nanovesicles in acute colitis through modulation of NLRP3 inflammasome. Biomolecules, 11(2), 162. https://doi.org/10.3390/biom11020162
  • Mishra, R. K., Ahmad, A., Kumar, A., Ali, A., Kanika, Jori, C., Tabrez, S., Zughaibi, T. A., Almashjary, M. N., Raza, S. S., & Khan, R. (2023). Cortisone-loaded stearoyl ascorbic acid based nanostructured lipid carriers alleviate inflammatory changes in DSS-induced colitis. Biomaterials advances, 148, 213383. https://doi.org/10.1016/j.bioadv.2023.213383
  • Mishra, R. K., Ahmad, A., Kumar, A., Vyawahare, A., Raza, S. S., & Khan, R. (2020). Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis. Materials science & engineering. C, Materials for biological applications, 116, 111103. https://doi.org/10.1016/j.msec.2020.111103
  • Müller, R. H., Shegokar, R., & Keck, C. M. (2011). 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Current drug discovery technologies, 8(3), 207–227. https://doi.org/10.2174/157016311796799062
  • Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022). Liposomes: structure, composition, types, and clinical applications. Heliyon, 8(5), e09394. https://doi.org/10.1016/j.heliyon.2022.e09394
  • Nyandoro, V. O., Omolo, C. A., Ismail, E. A., Yong, L., & Govender, T. (2023). Inflammation-responsive drug delivery nanosystems for treatment of bacterial-induced sepsis. International journal of pharmaceutics, 644, 123346. https://doi.org/10.1016/j.ijpharm.2023.123346
  • Olival, A., Vieira, S. F., Gonçalves, V. M. F., Cunha, C., Tiritan, M. E., Carvalho, A., Reis, R. L., Ferreira, H., & Neves, N. M. (2022). Erythrocyte-derived liposomes for the treatment of inflammatory diseases. Journal of drug targeting, 30(8), 873–883. https://doi.org/10.1080/1061186X.2022.2066107
  • Pal, R. R., Rajpal, V., Singh, N., Singh, S., Mishra, N., Singh, P., Maurya, P., Alka, &Saraf, S. A. (2023). Downregulation of pro-inflammatory markers IL-6 and TNF-α in rheumatoid arthritis using nano-lipidic carriers of a quinone-based phenolic: an in vitro and in vivo study. Drug delivery and translational research, 13(2), 627–641. https://doi.org/10.1007/s13346-022-01221-7
  • Paradkar, M., & Vaghela, S. (2018). Thiocolchicoside niosomal gel formulation for the pain management of rheumatoid arthritis through topical drug delivery. Drug Delivery Letters, 8(2), 159-168. https://doi.org/10.2174/2210303108666180216151234
  • Pham, C. T. (2011). Nanotherapeutic approaches for the treatment of rheumatoid arthritis. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 3(6), 607-619. https://doi.org/10.1002/wnan.157
  • Plaza-Oliver, M., Beloqui, A., Santander-Ortega, M. J., Castro-Vázquez, L., Rodríguez-Robledo, V., Arroyo-Jiménez, M. M., Préat, V., & Lozano, M. V. (2020). Ascorbyl-dipalmitate-stabilised nanoemulsions as a potential localised treatment of inflammatory bowel diseases. International journal of pharmaceutics, 586, 119533. https://doi.org/10.1016/j.ijpharm.2020.119533
  • Plaza-Oliver, M., Santander-Ortega, M. J., & Lozano, M. V. (2021). Current approaches in lipid-based nanocarriers for oral drug delivery. Drug delivery and translational research, 11(2), 471–497. https://doi.org/10.1007/s13346-021-00908-7
  • Preeti, Sambhakar, S., Malik, R., Bhatia, S., Al Harrasi, A., Rani, C., Saharan, R., Kumar, S., Geeta, & Sehrawat, R. (2023). Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs. Scientifica, 2023, 6640103. https://doi.org/10.1155/2023/6640103
  • Raj, S., & Unsworth, L. D. (2023). Targeting active sites of inflammation using inherent properties of tissue-resident mast cells. Acta biomaterialia, 159, 21–37. https://doi.org/10.1016/j.actbio.2023.01.024
  • Rajizadeh, M. A., Najafipour, H., SamarehFekr, M., Rostamzadeh, F., Jafari, E., Bejeshk, M. A., & Masoumi-Ardakani, Y. (2019). Anti-Inflammatory and Anti-Oxidative Effects of Myrtenol in the Rats with Allergic Asthma. Iranian journal of pharmaceutical research: IJPR, 18(3), 1488–1498. https://doi.org/10.22037/ijpr.2019.1100749
  • Rajizadeh, M. A., Nematollahi, M. H., Jafari, E., Bejeshk, M. A., Mehrabani, M., Razeghinia, M. S., & Najafipour, H. (2023). Niosome nanocarrier enhances the ameliorating effects of myrtenol in the lungs of rats with experimental asthma. OpenNano, 11, 100129. https://doi.org/10.1016/j.onano.2023.100129
  • Rapalli, V. K., Kaul, V., Waghule, T., Gorantla, S., Sharma, S., Roy, A., Dubey, S. K., & Singhvi, G. (2020). Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition. European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences, 152, 105438. https://doi.org/10.1016/j.ejps.2020.105438
  • Rathi, R., Kaur, S., Chopra, H., Kaur, M., Kumar, S. & Singh, I. (2024). Advancements in microsponges for the management of vaginal and colorectal diseases: A comprehensive review. Applied Chemical Engineering, 2334-2334. 10.59429/ace.v7i2.2334
  • Rinaldi, F., Del Favero, E., Rondelli, V., Pieretti, S., Bogni, A., Ponti, J., Rossi, F., Di Marzio, L., Paolino, D., Marianecci, C., & Carafa, M. (2017).pH-sensitive niosomes: Effects on cytotoxicity and on inflammation and pain in murine models. Journal of enzyme inhibition and medicinal chemistry, 32(1), 538–546. https://doi.org/10.1080/14756366.2016.1268607
  • Rizvi, S. A. A., & Saleh, A. M. (2018).Applications of nanoparticle systems in drug delivery technology. Saudi pharmaceutical journal: SPJ : the official publication of the Saudi Pharmaceutical Society, 26(1), 64–70. https://doi.org/10.1016/j.jsps.2017.10.012
  • Roe, K. (2021). An inflammation classification system using cytokine parameters. Scandinavian journal of immunology, 93(2), e12970. https://doi.org/10.1111/sji.12970
  • Rossi, J. F., Lu, Z. Y., Massart, C., & Levon, K. (2021). Dynamic Immune/Inflammation Precision Medicine: The Good and the Bad Inflammation in Infection and Cancer. Frontiers in immunology, 12, 595722. https://doi.org/10.3389/fimmu.2021.595722
  • Sathe, P., Saka, R., Kommineni, N., Raza, K., & Khan, W. (2019). Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Drug development and industrial pharmacy, 45(5), 826–838. https://doi.org/10.1080/03639045.2019.1576722
  • Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015). Advances and Challenges of Liposome Assisted Drug Delivery. Frontiers in pharmacology, 6, 286. https://doi.org/10.3389/fphar.2015.00286
  • Sharma, M., Rathi, R., Kaur, S., Singh, I., Abd Kadir, E., Chahardehi, A. M., & Lim, V. (2023). Antiinflammatory activity of herbal bioactive-based formulations for topical administration. In Recent Developments in Anti-Inflammatory Therapy, 245-277. Academic Press. https://doi.org/10.1016/B978-0-323-99988-5.00015-2
  • Shinde, C., Venkatesh, M. P., Pramod Kumar, T., & Pai, D. R. (2021). Nanostructured lipid carrier-based smart gel: a delivery platform for intra-articular therapeutics. Autoimmunity, 54(1), 35–44. https://doi.org/10.1080/08916934.2020.1846184
  • Souto, E. B., Cano, A., Martins-Gomes, C., Coutinho, T. E., Zielińska, A., & Silva, A. M. (2022). Microemulsions and Nanoemulsions in Skin Drug Delivery. Bioengineering (Basel, Switzerland), 9(4), 158. https://doi.org/10.3390/bioengineering9040158
  • Subramaniam, S., Elz, A., Wignall, A., Kamath, S., Ariaee, A., Hunter, A., Newblack, T., Wardill, H. R., Prestidge, C. A., & Joyce, P. (2023). Self-emulsifying drug delivery systems (SEDDS) disrupt the gut microbiota and trigger an intestinal inflammatory response in rats. International journal of pharmaceutics, 648, 123614. https://doi.org/10.1016/j.ijpharm.2023.123614
  • Tetyczka, C., Hartl, S., Jeitler, R., Absenger-Novak, M., Meindl, C., Fröhlich, E., Riedl, S., Zweytick, D., & Roblegg, E. (2021).Cytokine-Mediated Inflammation in the Oral Cavity and Its Effect on Lipid Nanocarriers. Nanomaterials (Basel, Switzerland), 11(5), 1330. https://doi.org/10.3390/nano11051330
  • Umerska, A., Mouzouvi, C. R., Bigot, A., & Saulnier, P. (2015).Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers. International journal of pharmaceutics, 493(1-2), 224–232. https://doi.org/10.1016/j.ijpharm.2015.07.008
  • Viegas, J. S. R., Praça, F. G., Caron, A. L., Suzuki, I., Silvestrini, A. V. P., Medina, W. S. G., Del Ciampo, J. O., Kravicz, M., & Bentley, M. V. L. B. (2020). Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis. Drug delivery and translational research, 10(3), 646–660. https://doi.org/10.1007/s13346-020-00723-6
  • Walunj, M., Doppalapudi, S., Bulbake, U., & Khan, W. (2020). Preparation, characterization, and in vivo evaluation of cyclosporine cationic liposomes for the treatment of psoriasis. Journal of liposome research, 30(1), 68–79. https://doi.org/10.1080/08982104.2019.1593449
  • Wen, J., Li, H., Dai, H., Hua, S., Long, X., Li, H., ... & Xu, C. (2023). Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management. Materials Today Bio, 19, 100597. https://doi.org/10.1016/j.mtbio.2023.100597
  • Witika, B. A., Bassey, K. E., Demana, P. H., Siwe-Noundou, X., & Poka, M. S. (2022). Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications. International journal of molecular sciences, 23(17), 9668. https://doi.org/10.3390/ijms23179668
  • Yang, C., & Merlin, D. (2019). Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives. International journal of nanomedicine, 14, 8875–8889. https://doi.org/10.2147/IJN.S210315
  • Yasmin, F., Najeeb, H., Shaikh, S., Hasanain, M., Naeem, U., Moeed, A., Koritala, T., Hasan, S., & Surani, S. (2022). Novel drug delivery systems for inflammatory bowel disease. World journal of gastroenterology, 28(18), 1922–1933. https://doi.org/10.3748/wjg.v28.i18.1922
  • Zhao, Y., Yang, Y., Zhang, J., Wang, R., Cheng, B., Kalambhe, D., ... & Huang, Y. (2020). Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases. Acta Pharmaceutica Sinica B, 10(10), 1966-1976. https://doi.org/10.1016/j.apsb.2020.07.019
  • Zuo, X., Gu, Y., Guo, X., Zheng, W., Zheng, H., An, Y., ... & Wang, F. (2024). Preparation of Budesonide-Loaded Liposomal Nanoparticles for Pulmonary Delivery and Their Therapeutic Effect in OVA-Induced Asthma in Mice. International journal of nanomedicine, 673-688. https://doi.org/10.2147/IJN.S441345